Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China · Delayed Price · Currency is CNY 32.04
+0.32 (1.01%)
Apr 29, 2026, 3:00 PM CST
SHA:600976 Revenue
Jianmin Pharmaceutical Group had revenue of 873.07M CNY in the quarter ending March 31, 2026, a decrease of -2.13%. This brings the company's revenue in the last twelve months to 3.35B, down -2.22% year-over-year. In the year 2025, Jianmin Pharmaceutical Group had annual revenue of 3.37B, down -3.85%.
Revenue (ttm)
3.35B
Revenue Growth
-2.22%
P/S Ratio
1.45
Revenue / Employee
1.48M
Employees
2,257
Market Cap
4.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.37B | -135.08M | -3.85% |
| Dec 31, 2024 | 3.50B | -708.17M | -16.81% |
| Dec 31, 2023 | 4.21B | 572.35M | 15.72% |
| Dec 31, 2022 | 3.64B | 341.37M | 10.35% |
| Dec 31, 2021 | 3.30B | 843.43M | 34.34% |
| Jan 1, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yabao Pharmaceutical Group | 2.20B |
| Hunan Fangsheng Pharmaceutical | 1.79B |
| Fuan Pharmaceutical (Group) | 1.68B |
| Bide Pharmatech | 1.32B |
| Teyi Pharmaceutical Group Co.,Ltd | 924.53M |
| Nanjing Hicin Pharmaceutical | 688.74M |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 543.82M |
| Hubei Biocause Heilen Pharmaceutical | 459.02M |